Neurogenesis

Neurodegenerative Disease Cell Therapy

Health Tech & Life Sciences
Active
Series A Ramat Gan, Israel Founded 2018
Website ↗
Last updated 2026-06-18
Total raised
$7.7M
Last: 2026-05
Stage
Series A
Founded
2018
Headcount
5
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

NeuroGenesis is a clinical-stage cellular therapy company that focuses on utilizing a proprietary subpopulation of bone marrow stem cells. These cells are specifically selected and enhanced to become remyelinating and regenerative biofactory cells. The company's platform, NG CELL technology, is specifically designed to treat central nervous system diseases, such as progressive multiple sclerosis and amyotrophic lateral sclerosis.

Funding history · 2 rounds · $7.7M total

2022-03
$6.7M
RhodiumExcell PartnersDaniel Recanati
2026-05

Q&A

What is Neurogenesis's primary focus?
Neurogenesis is a clinical-stage cellular therapy company focused on utilizing a proprietary subpopulation of bone marrow stem cells to treat central nervous system diseases like progressive multiple sclerosis and amyotrophic lateral sclerosis.
When was Neurogenesis founded?
Neurogenesis was founded in September 2018.
How many employees does Neurogenesis have?
Neurogenesis has 1-10 employees.
What is Neurogenesis's total funding to date?
Neurogenesis has raised a total of $7,660,000.
When was Neurogenesis's most recent funding round and who participated?
In May 2026, Neurogenesis received a grant of $1,000,000 from BIRD Foundation.
Which investors participated in Neurogenesis's March 2022 funding round?
In March 2022, Rhodium and Excell Partners participated in a private funding round for Neurogenesis.
Who are the co-founders of Neurogenesis?
The co-founders of Neurogenesis are Tal Gilat (CEO), Ibrahim Kassis (CTO), and Dimitrios Karussis (CSO).
Where is Neurogenesis headquartered?
Neurogenesis is headquartered in Ramat Gan, Israel.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co- founder & CTO
LinkedIn ↗
Founder · Co-founder & CSO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesHealthcare
Business model
B2B

Tags

pharmaceuticalscell-therapyamyotrophic-lateral-sclerosis-als
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteneurogenesis-cell.com/

Identifiers & details

Founded2018-9
Employees (exact)5
OfficesRochester

Radar intelligence

Patents

EPO4

Publications (Crossref)

Works10

Web history (Wayback)

Domainneurogenesis-cell.com

Certificate / subdomain footprint

Subdomains2